GSK PLC's ticker is and the CUSIP is 37733W204. A total of 63 filers reported holding GSK PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,139 | -23.4% | 3,259 | -24.6% | 0.03% | -16.7% |
| Q2 2023 | $154,143 | +0.2% | 4,325 | 0.0% | 0.04% | +5.9% |
| Q1 2023 | $153,884 | +2.7% | 4,325 | +1.4% | 0.03% | 0.0% |
| Q4 2022 | $149,907 | +19.0% | 4,266 | 0.0% | 0.03% | -38.2% |
| Q3 2022 | $126,000 | -45.7% | 4,266 | -20.0% | 0.06% | -1.8% |
| Q2 2022 | $232,000 | – | 5,333 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 17,971,970 | $631,445 | 54.05% |
| Eversept Partners, LP | 3,490,457 | $123,825,940 | 10.84% |
| HealthInvest Partners AB | 150,000 | $5,271,000 | 10.18% |
| Eversept Partners, LP | 2,093,700 | $73,572,618 | 6.44% |
| Camber Capital Management LP | 3,750,000 | $131,775 | 4.52% |
| Robinson Value Management, Ltd. | 132,118 | $4,642,627 | 4.00% |
| EQUITY INVESTMENT CORP | 2,877,793 | $101,125,646 | 3.40% |
| Hillman Capital Management, Inc. | 237,879 | $8,359,068 | 3.28% |
| Keystone Financial Planning, Inc. | 264,080 | $9,279,778 | 3.13% |
| Clean Yield Group | 187,728 | $6,596,762 | 2.83% |